Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass

Background Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity surgery 2017-02, Vol.27 (2), p.376-380
Hauptverfasser: Winder, Joshua S, Dudeck, Brandon S., Schock, Sarayna, Lyn-Sue, Jerome R., Haluck, Randy S., Rogers, Ann M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 380
container_issue 2
container_start_page 376
container_title Obesity surgery
container_volume 27
creator Winder, Joshua S
Dudeck, Brandon S.
Schock, Sarayna
Lyn-Sue, Jerome R.
Haluck, Randy S.
Rogers, Ann M.
description Background Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed tomographic (CT) findings of NAFLD include low attenuation of liver parenchyma and hepatomegaly. We hypothesized that patients experiencing significant weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB) would show CT improvement of NAFLD. Methods A retrospective review was performed on primary LRYGB patients at this institution from 2006 to 2014. We identified patients with either a preoperative abdominal CT or an early postoperative scan (prior to significant weight loss) as well as those with scans performed at >60 days postoperation. Radiologic interpretations were reviewed; descriptions of steatosis, hypodensity, fatty infiltration, fatty liver, fatty changes, or liver parenchyma measuring ≤40 Hounsfield units averaged at three locations on non-contrast CT were documented. Later, scans were reviewed for improvement by these criteria. Results Nineteen patients had perioperative radiographic evidence of NAFLD, with 89.5 % female, average age 41.5, and median body mass index (BMI) 46.9 kg/m 2 . Sixteen (84.2 %) showed radiographic improvement of NAFLD. The median time between scans was 826 days, with median BMI at that point of 30.5 kg/m 2 . The three without radiographic improvement still experienced significant weight loss (average BMI points lost = 19.3 kg/m 2 , ±5.6). Conclusions While weight loss and comorbidity improvement are common, they are not universal after LRYGB. Radiographic improvement of NAFLD in 84 % of patients was salutary.
doi_str_mv 10.1007/s11695-016-2299-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826725376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826725376</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-2b7c9cb4b576805deca594e40a162aa92fbc31bf754389fd102074d72be9b05e3</originalsourceid><addsrcrecordid>eNp1kEtLxTAQhYMoen38ADdScOMmOkmTplmq-IILgo-Fq5CmU63cNjVpRf-9kasigqvAzHdOzhxCdhkcMgB1FBkrtKTACsq51lSukBlTUFIQvFwlM9AF0FLzfINsxvgMwFnB-TrZ4EqIpFIz8nBj69Y_Bjs8tS676obgX7HDfsx8k13iYMc0vh3Rjj62MTtuRgzZ3A42-Oj8kJY3fnqj2NOH7MLGMaTJyftgY9wma41dRNz5erfI_fnZ3eklnV9fXJ0ez6nLFR8pr5TTrhKVVEUJskZnpRYowKas1mreVC5nVaOkyEvd1Aw4KFErXqGuQGK-RQ6Wvin6y4RxNF0bHS4Wtkc_RcNKXiguc1UkdP8P-uyn0Kd0iZJlASJZJ4otKZdujAEbM4S2s-HdMDCfvZtl7yY1aD57NzJp9r6cp6rD-kfxXXQC-BKIadU_Yvj19b-uH3dJjQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1858604074</pqid></control><display><type>article</type><title>Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Winder, Joshua S ; Dudeck, Brandon S. ; Schock, Sarayna ; Lyn-Sue, Jerome R. ; Haluck, Randy S. ; Rogers, Ann M.</creator><creatorcontrib>Winder, Joshua S ; Dudeck, Brandon S. ; Schock, Sarayna ; Lyn-Sue, Jerome R. ; Haluck, Randy S. ; Rogers, Ann M.</creatorcontrib><description>Background Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed tomographic (CT) findings of NAFLD include low attenuation of liver parenchyma and hepatomegaly. We hypothesized that patients experiencing significant weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB) would show CT improvement of NAFLD. Methods A retrospective review was performed on primary LRYGB patients at this institution from 2006 to 2014. We identified patients with either a preoperative abdominal CT or an early postoperative scan (prior to significant weight loss) as well as those with scans performed at &gt;60 days postoperation. Radiologic interpretations were reviewed; descriptions of steatosis, hypodensity, fatty infiltration, fatty liver, fatty changes, or liver parenchyma measuring ≤40 Hounsfield units averaged at three locations on non-contrast CT were documented. Later, scans were reviewed for improvement by these criteria. Results Nineteen patients had perioperative radiographic evidence of NAFLD, with 89.5 % female, average age 41.5, and median body mass index (BMI) 46.9 kg/m 2 . Sixteen (84.2 %) showed radiographic improvement of NAFLD. The median time between scans was 826 days, with median BMI at that point of 30.5 kg/m 2 . The three without radiographic improvement still experienced significant weight loss (average BMI points lost = 19.3 kg/m 2 , ±5.6). Conclusions While weight loss and comorbidity improvement are common, they are not universal after LRYGB. Radiographic improvement of NAFLD in 84 % of patients was salutary.</description><identifier>ISSN: 0960-8923</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1007/s11695-016-2299-5</identifier><identifier>PMID: 27440167</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Comorbidity ; Fatty Liver - complications ; Fatty Liver - diagnosis ; Fatty Liver - epidemiology ; Fatty Liver - surgery ; Female ; Gastric Bypass - methods ; Gastrointestinal surgery ; Humans ; Laparoscopy - methods ; Liver Cirrhosis ; Liver diseases ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Non-alcoholic Fatty Liver Disease - complications ; Non-alcoholic Fatty Liver Disease - diagnosis ; Non-alcoholic Fatty Liver Disease - epidemiology ; Non-alcoholic Fatty Liver Disease - surgery ; Obesity ; Obesity, Morbid - complications ; Obesity, Morbid - diagnosis ; Obesity, Morbid - epidemiology ; Obesity, Morbid - surgery ; Original Contributions ; Postoperative Period ; Retrospective Studies ; Surgery ; Surgical outcomes ; Tomography ; Tomography, X-Ray Computed ; Treatment Outcome ; Weight Loss - physiology</subject><ispartof>Obesity surgery, 2017-02, Vol.27 (2), p.376-380</ispartof><rights>Springer Science+Business Media New York 2016</rights><rights>Obesity Surgery is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-2b7c9cb4b576805deca594e40a162aa92fbc31bf754389fd102074d72be9b05e3</citedby><cites>FETCH-LOGICAL-c372t-2b7c9cb4b576805deca594e40a162aa92fbc31bf754389fd102074d72be9b05e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11695-016-2299-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11695-016-2299-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27440167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winder, Joshua S</creatorcontrib><creatorcontrib>Dudeck, Brandon S.</creatorcontrib><creatorcontrib>Schock, Sarayna</creatorcontrib><creatorcontrib>Lyn-Sue, Jerome R.</creatorcontrib><creatorcontrib>Haluck, Randy S.</creatorcontrib><creatorcontrib>Rogers, Ann M.</creatorcontrib><title>Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass</title><title>Obesity surgery</title><addtitle>OBES SURG</addtitle><addtitle>Obes Surg</addtitle><description>Background Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed tomographic (CT) findings of NAFLD include low attenuation of liver parenchyma and hepatomegaly. We hypothesized that patients experiencing significant weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB) would show CT improvement of NAFLD. Methods A retrospective review was performed on primary LRYGB patients at this institution from 2006 to 2014. We identified patients with either a preoperative abdominal CT or an early postoperative scan (prior to significant weight loss) as well as those with scans performed at &gt;60 days postoperation. Radiologic interpretations were reviewed; descriptions of steatosis, hypodensity, fatty infiltration, fatty liver, fatty changes, or liver parenchyma measuring ≤40 Hounsfield units averaged at three locations on non-contrast CT were documented. Later, scans were reviewed for improvement by these criteria. Results Nineteen patients had perioperative radiographic evidence of NAFLD, with 89.5 % female, average age 41.5, and median body mass index (BMI) 46.9 kg/m 2 . Sixteen (84.2 %) showed radiographic improvement of NAFLD. The median time between scans was 826 days, with median BMI at that point of 30.5 kg/m 2 . The three without radiographic improvement still experienced significant weight loss (average BMI points lost = 19.3 kg/m 2 , ±5.6). Conclusions While weight loss and comorbidity improvement are common, they are not universal after LRYGB. Radiographic improvement of NAFLD in 84 % of patients was salutary.</description><subject>Adult</subject><subject>Comorbidity</subject><subject>Fatty Liver - complications</subject><subject>Fatty Liver - diagnosis</subject><subject>Fatty Liver - epidemiology</subject><subject>Fatty Liver - surgery</subject><subject>Female</subject><subject>Gastric Bypass - methods</subject><subject>Gastrointestinal surgery</subject><subject>Humans</subject><subject>Laparoscopy - methods</subject><subject>Liver Cirrhosis</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - complications</subject><subject>Non-alcoholic Fatty Liver Disease - diagnosis</subject><subject>Non-alcoholic Fatty Liver Disease - epidemiology</subject><subject>Non-alcoholic Fatty Liver Disease - surgery</subject><subject>Obesity</subject><subject>Obesity, Morbid - complications</subject><subject>Obesity, Morbid - diagnosis</subject><subject>Obesity, Morbid - epidemiology</subject><subject>Obesity, Morbid - surgery</subject><subject>Original Contributions</subject><subject>Postoperative Period</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Tomography</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Weight Loss - physiology</subject><issn>0960-8923</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kEtLxTAQhYMoen38ADdScOMmOkmTplmq-IILgo-Fq5CmU63cNjVpRf-9kasigqvAzHdOzhxCdhkcMgB1FBkrtKTACsq51lSukBlTUFIQvFwlM9AF0FLzfINsxvgMwFnB-TrZ4EqIpFIz8nBj69Y_Bjs8tS676obgX7HDfsx8k13iYMc0vh3Rjj62MTtuRgzZ3A42-Oj8kJY3fnqj2NOH7MLGMaTJyftgY9wma41dRNz5erfI_fnZ3eklnV9fXJ0ez6nLFR8pr5TTrhKVVEUJskZnpRYowKas1mreVC5nVaOkyEvd1Aw4KFErXqGuQGK-RQ6Wvin6y4RxNF0bHS4Wtkc_RcNKXiguc1UkdP8P-uyn0Kd0iZJlASJZJ4otKZdujAEbM4S2s-HdMDCfvZtl7yY1aD57NzJp9r6cp6rD-kfxXXQC-BKIadU_Yvj19b-uH3dJjQU</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Winder, Joshua S</creator><creator>Dudeck, Brandon S.</creator><creator>Schock, Sarayna</creator><creator>Lyn-Sue, Jerome R.</creator><creator>Haluck, Randy S.</creator><creator>Rogers, Ann M.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass</title><author>Winder, Joshua S ; Dudeck, Brandon S. ; Schock, Sarayna ; Lyn-Sue, Jerome R. ; Haluck, Randy S. ; Rogers, Ann M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-2b7c9cb4b576805deca594e40a162aa92fbc31bf754389fd102074d72be9b05e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Comorbidity</topic><topic>Fatty Liver - complications</topic><topic>Fatty Liver - diagnosis</topic><topic>Fatty Liver - epidemiology</topic><topic>Fatty Liver - surgery</topic><topic>Female</topic><topic>Gastric Bypass - methods</topic><topic>Gastrointestinal surgery</topic><topic>Humans</topic><topic>Laparoscopy - methods</topic><topic>Liver Cirrhosis</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - complications</topic><topic>Non-alcoholic Fatty Liver Disease - diagnosis</topic><topic>Non-alcoholic Fatty Liver Disease - epidemiology</topic><topic>Non-alcoholic Fatty Liver Disease - surgery</topic><topic>Obesity</topic><topic>Obesity, Morbid - complications</topic><topic>Obesity, Morbid - diagnosis</topic><topic>Obesity, Morbid - epidemiology</topic><topic>Obesity, Morbid - surgery</topic><topic>Original Contributions</topic><topic>Postoperative Period</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Tomography</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Weight Loss - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winder, Joshua S</creatorcontrib><creatorcontrib>Dudeck, Brandon S.</creatorcontrib><creatorcontrib>Schock, Sarayna</creatorcontrib><creatorcontrib>Lyn-Sue, Jerome R.</creatorcontrib><creatorcontrib>Haluck, Randy S.</creatorcontrib><creatorcontrib>Rogers, Ann M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winder, Joshua S</au><au>Dudeck, Brandon S.</au><au>Schock, Sarayna</au><au>Lyn-Sue, Jerome R.</au><au>Haluck, Randy S.</au><au>Rogers, Ann M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass</atitle><jtitle>Obesity surgery</jtitle><stitle>OBES SURG</stitle><addtitle>Obes Surg</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>27</volume><issue>2</issue><spage>376</spage><epage>380</epage><pages>376-380</pages><issn>0960-8923</issn><eissn>1708-0428</eissn><abstract>Background Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and the leading cause of cirrhosis in developed nations. Studies confirm improvement of liver histopathology after significant weight loss, but biochemistry and sonography do not always show this. Computed tomographic (CT) findings of NAFLD include low attenuation of liver parenchyma and hepatomegaly. We hypothesized that patients experiencing significant weight loss after laparoscopic Roux-en-Y gastric bypass (LRYGB) would show CT improvement of NAFLD. Methods A retrospective review was performed on primary LRYGB patients at this institution from 2006 to 2014. We identified patients with either a preoperative abdominal CT or an early postoperative scan (prior to significant weight loss) as well as those with scans performed at &gt;60 days postoperation. Radiologic interpretations were reviewed; descriptions of steatosis, hypodensity, fatty infiltration, fatty liver, fatty changes, or liver parenchyma measuring ≤40 Hounsfield units averaged at three locations on non-contrast CT were documented. Later, scans were reviewed for improvement by these criteria. Results Nineteen patients had perioperative radiographic evidence of NAFLD, with 89.5 % female, average age 41.5, and median body mass index (BMI) 46.9 kg/m 2 . Sixteen (84.2 %) showed radiographic improvement of NAFLD. The median time between scans was 826 days, with median BMI at that point of 30.5 kg/m 2 . The three without radiographic improvement still experienced significant weight loss (average BMI points lost = 19.3 kg/m 2 , ±5.6). Conclusions While weight loss and comorbidity improvement are common, they are not universal after LRYGB. Radiographic improvement of NAFLD in 84 % of patients was salutary.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>27440167</pmid><doi>10.1007/s11695-016-2299-5</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-8923
ispartof Obesity surgery, 2017-02, Vol.27 (2), p.376-380
issn 0960-8923
1708-0428
language eng
recordid cdi_proquest_miscellaneous_1826725376
source MEDLINE; SpringerLink Journals
subjects Adult
Comorbidity
Fatty Liver - complications
Fatty Liver - diagnosis
Fatty Liver - epidemiology
Fatty Liver - surgery
Female
Gastric Bypass - methods
Gastrointestinal surgery
Humans
Laparoscopy - methods
Liver Cirrhosis
Liver diseases
Male
Medicine
Medicine & Public Health
Middle Aged
Non-alcoholic Fatty Liver Disease - complications
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - epidemiology
Non-alcoholic Fatty Liver Disease - surgery
Obesity
Obesity, Morbid - complications
Obesity, Morbid - diagnosis
Obesity, Morbid - epidemiology
Obesity, Morbid - surgery
Original Contributions
Postoperative Period
Retrospective Studies
Surgery
Surgical outcomes
Tomography
Tomography, X-Ray Computed
Treatment Outcome
Weight Loss - physiology
title Radiographic Improvement of Hepatic Steatosis After Laparoscopic Roux-en-Y Gastric Bypass
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A19%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiographic%20Improvement%20of%20Hepatic%20Steatosis%20After%20Laparoscopic%20Roux-en-Y%20Gastric%20Bypass&rft.jtitle=Obesity%20surgery&rft.au=Winder,%20Joshua%20S&rft.date=2017-02-01&rft.volume=27&rft.issue=2&rft.spage=376&rft.epage=380&rft.pages=376-380&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1007/s11695-016-2299-5&rft_dat=%3Cproquest_cross%3E1826725376%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1858604074&rft_id=info:pmid/27440167&rfr_iscdi=true